Sort by
Refine Your Search
-
curricula and industry-engagement at our advanced production Futures Studio. They will also have the opportunity to work with the ground-breaking CoSTAR National R&D Lab, a £51.1m programme for converged
-
organised into six research centres which, though complementary and following the Institute’s strategic plan, also have Centre-specific objectives and requirements. The postholder will be based in the Centre
-
Responsibilities Provide timely and accurate administrative support for all Degree Education and PhD courses offered by the department. Liaise with the Central Services team and Programme Offices to ensure efficient
-
strategic plan, also have Centre-specific objectives and requirements. The postholder will be based in the Pragmatic Clinical Trials Unit (PCTU) in the Centre for Evaluation and Methods. The PCTU is a fully
-
Research Centre (BRC) programme is Precision Cardiovascular Genomic Medicine, co-led by Professors Panos Deloukas and Patricia Munroe. Our research focuses on (i) deep phenotyping with multi-omics and
-
pay benefit, free on-site gym and wellbeing centre a comprehensive learning and development programme and support for your CPD Prospective applicants are encouraged in the first instance to contact
-
assist with the delivery of teaching across the programme and will have the opportunity to co-lead a module. You will also assist with assessment and student support duties. The post holder will be
-
Television School, Pinewood, and the University of Surrey. This vital role works across the University’s Research and Innovation team and the StoryFutures Business unit to drive an ambitious R&D programme to
-
. The main responsibilities of the post are to support the Employer Engagement and Communications Manager in developing the annual Employer Engagement programme, forging strategically important relationships
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing